<--- Back to Details
First PageDocument Content
Bristol-Myers Squibb / Cetuximab / Eli Lilly and Company / Epidermal growth factor receptor / WT / Panitumumab / Biomarker / KRAS / Head and neck cancer
Date: 2016-08-08 11:30:22
Bristol-Myers Squibb
Cetuximab
Eli Lilly and Company
Epidermal growth factor receptor
WT
Panitumumab
Biomarker
KRAS
Head and neck cancer

PAN01 biomarker poster ESMO 15.pdf

Add to Reading List

Source URL: www.ctueoc.ch

Download Document from Source Website

File Size: 112,34 KB

Share Document on Facebook

Similar Documents

Date: Head and Neck Cancer Alliance PO BoxCharleston, SCDear Head and Neck Cancer Alliance:

DocID: 1tlbA - View Document

AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC

DocID: 1rVAJ - View Document

Clinical medicine / Medicine / Cancer / Cancer treatments / RTT / Brain tumor / Bevacizumab / Glioblastoma / Head and neck cancer / Temozolomide / Adjuvant therapy / Chemotherapy

Lettre d’information du réseau GCO - Spéciale ASCOLes Groupes Coopérateurs en Oncologie à l’ASCO 2016 Les Groupes Coopérateurs en Oncologie (GCO) seront représentés au 52ème congrès de l’ASCO (Ameri

DocID: 1qX2r - View Document

Medicine / Health / Clinical medicine / RTT / Nutrition / Infectious causes of cancer / Applied sciences / Food science / Cachexia / Cancer / Prostate cancer / Head and neck cancer

Nutrition and Cancer: Frontiers for Cure! Gregory K. Ogilvie, DVM Diplomate ACVIM (Specialties of Internal Medicine and Oncology), Professor of Oncology and Internal Medicine Animal Cancer Center, Medical Oncology Resear

DocID: 1q8XC - View Document

Cancer / Clinical medicine / Health / Infectious causes of cancer / RTT / Gynaecological cancer / Papillomavirus / Otorhinolaryngology / Human papillomavirus infection / Head and neck cancer / Oropharyngeal cancer / Cervical cancer

ENGLISH SUMMARY Persistent high-risk HPV infection has been associated with the development of cervical, vaginal, vulvar, anal and penile cancers, although the proportions attributable to HPV vary by cancer site. Lately,

DocID: 1pUdx - View Document